Keyphrases
Hemodialysis Patients
100%
Ferumoxytol
100%
Iron Replacement Therapy
100%
Intravenous Iron Replacement
100%
Oral Iron
77%
Hemoglobin
66%
Intravenous Iron
22%
Transferrin Saturation
22%
Between-group
11%
Chronic Kidney Disease
11%
Intravenous Injection
11%
Phase II Trial
11%
Efficacy Endpoint
11%
Hemodialysis
11%
Tolerability
11%
Adverse Event Rates
11%
Rapid Injection
11%
Maintenance Hemodialysis Patients
11%
Anemic Patients
11%
Serum Ferritin
11%
Chronic Kidney Disease Stage
11%
Erythropoiesis-stimulating Agents
11%
Anemia Management
11%
Iron Products
11%
Medicine and Dentistry
Hemodialysis
100%
Substitution Therapy
100%
Ferumoxytol
100%
Iron
100%
Chronic Kidney Disease
22%
Transferrin Saturation
22%
Adverse Event
11%
Anemia
11%
Intravenous Drug Administration
11%
Ferritin
11%
Hematinic
11%
Iron Product
11%
Pharmacology, Toxicology and Pharmaceutical Science
Replacement Therapy
100%
Hemodialysis
100%
Ferumoxytol
100%
Iron
100%
Chronic Kidney Failure
20%
Transferrin
20%
Anemia
10%
Adverse Event
10%
Tolerability
10%
Ferritin
10%
Antianemic Agent
10%